Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur G Pratt

Showing results (21-30 of 74) with videos related to

Pageof 8
Sort By:
Plos Genetics|September 29, 2021
A Bayesian network approach incorporating imputation of missing data enables exploratory analysis of complex causal biological relationshipsRichard Howey, Alexander D Clark, Najib Naamane, et al.
Annals of the Rheumatic Diseases|May 31, 2011
Serotyping for an extended anti-citrullinated peptide autoantibody panel does not add value to CCP2 testing for diagnosing RA in an early undifferentiated arthritis cohortArthur G Pratt, Peter J Charles, Muslima Chowdhury, et al.
Drug Discovery Today|December 14, 2019
Schrödinger's pipeline and the outsourcing of pharmaceutical innovationPeter McMeekin, Dennis W Lendrem, B Clare Lendrem, et al.
Rheumatology Advances in Practice|January 9, 2026
Rheumatoid arthritis and osteoarthritis patients demonstrate comparable rates of major adverse cardiovascular events: a single-centre retrospective cohort studyChung M A Lin, Hadeel M Tabaqchali, Stephen White, et al.
Journal of Autoimmunity|July 9, 2019
Predicting drug-free remission in rheumatoid arthritis: A prospective interventional cohort studyKenneth F Baker, Andrew J Skelton, Dennis W Lendrem, et al.
Rheumatology (Oxford, England)|November 20, 2014
Retrospective analysis of the role of serum vitamin D in early rheumatic diseaseFaye A H Cooles, Arthur G Pratt, Dennis W Lendrem, et al.
Journal of Autoimmunity|September 22, 2022
Erratum to "Predicting drug-free remission in rheumatoid arthritis: A prospective interventional cohort study" [J. Autoimmun. 105 (December 2019) 102298]Kenneth F Baker, Andrew J Skelton, Dennis W Lendrem, et al.
RMD Open|February 17, 2024
Adenosine metabolic signature in circulating CD4+ T cells predicts remission in rheumatoid arthritisPhilip M Brown, Amy E Anderson, Najib Naamane, et al.
Annals of the Rheumatic Diseases|April 26, 2012
A CD4 T cell gene signature for early rheumatoid arthritis implicates interleukin 6-mediated STAT3 signalling, particularly in anti-citrullinated peptide antibody-negative diseaseArthur G Pratt, Daniel C Swan, Sarah Richardson, et al.
The Journal of Allergy and Clinical Immunology|October 9, 2017
The interferon gene signature is increased in patients with early treatment-naive rheumatoid arthritis and predicts a poorer response to initial therapyFaye A H Cooles, Amy E Anderson, Dennis W Lendrem, et al.
Pageof 8

Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Plos Genetics|September 29, 2021
A Bayesian network approach incorporating imputation of missing data enables exploratory analysis of complex causal biological relationshipsRichard Howey, Alexander D Clark, Najib Naamane, et al.
Annals of the Rheumatic Diseases|May 31, 2011
Serotyping for an extended anti-citrullinated peptide autoantibody panel does not add value to CCP2 testing for diagnosing RA in an early undifferentiated arthritis cohortArthur G Pratt, Peter J Charles, Muslima Chowdhury, et al.
Drug Discovery Today|December 14, 2019
Schrödinger's pipeline and the outsourcing of pharmaceutical innovationPeter McMeekin, Dennis W Lendrem, B Clare Lendrem, et al.
Rheumatology Advances in Practice|January 9, 2026
Rheumatoid arthritis and osteoarthritis patients demonstrate comparable rates of major adverse cardiovascular events: a single-centre retrospective cohort studyChung M A Lin, Hadeel M Tabaqchali, Stephen White, et al.
Journal of Autoimmunity|July 9, 2019
Predicting drug-free remission in rheumatoid arthritis: A prospective interventional cohort studyKenneth F Baker, Andrew J Skelton, Dennis W Lendrem, et al.
Rheumatology (Oxford, England)|November 20, 2014
Retrospective analysis of the role of serum vitamin D in early rheumatic diseaseFaye A H Cooles, Arthur G Pratt, Dennis W Lendrem, et al.
Journal of Autoimmunity|September 22, 2022
Erratum to "Predicting drug-free remission in rheumatoid arthritis: A prospective interventional cohort study" [J. Autoimmun. 105 (December 2019) 102298]Kenneth F Baker, Andrew J Skelton, Dennis W Lendrem, et al.
RMD Open|February 17, 2024
Adenosine metabolic signature in circulating CD4+ T cells predicts remission in rheumatoid arthritisPhilip M Brown, Amy E Anderson, Najib Naamane, et al.
Annals of the Rheumatic Diseases|April 26, 2012
A CD4 T cell gene signature for early rheumatoid arthritis implicates interleukin 6-mediated STAT3 signalling, particularly in anti-citrullinated peptide antibody-negative diseaseArthur G Pratt, Daniel C Swan, Sarah Richardson, et al.
The Journal of Allergy and Clinical Immunology|October 9, 2017
The interferon gene signature is increased in patients with early treatment-naive rheumatoid arthritis and predicts a poorer response to initial therapyFaye A H Cooles, Amy E Anderson, Dennis W Lendrem, et al.
Pageof 8